Paralogs of the bifunctional nuclease, Ribonuclease J (RNase J), demonstrate varied catalytic efficiencies despite extensive sequence and structural similarity. Of the two Staphylococcus aureus RNase J paralogues, RNase J1 is substantially more active than RNase J2. Mutational analysis of active site residues revealed that only H80 and E166 were critical for nuclease activity. Electronic properties of active site residues were further evaluated using density functional theory in conjunction with molecular mechanics. This analysis suggested that multiple residues at the active site can function as Lewis bases or acids in RNase J2. The bond dissociation energy, on the other hand, suggested that the Mn ion in RNase J2, located at a structurally identical location to that in RNase J1, is crucial for overall structural integrity. Structures of mutant enzymes lacking the metal ion were seen to adopt a different orientation between the substrate binding and catalytic domain than wild-type RNase J2. A surprising finding was that the RNase J2 H78 A mutant was five-fold more active than the wild-type enzyme. Structural and biochemical experiments performed in light of this observation revealed that the RNase J2 catalytic mechanism is distinct from both two-metal ion and one-metal ion reaction mechanisms proposed for RNase J nucleases. Different activity levels in RNase J paralogues can thus be ascribed to the diversity in catalytic mechanisms.
Plasmodium falciparum plasmepsin X ( Pf PMX), involved in the invasion and egress of this deadliest malarial parasite, is essential for its survival and hence considered as an important drug target. We report the first crystal structure of Pf PMX zymogen containing a novel fold of its prosegment. A unique twisted loop from the prosegment and arginine 244 from the mature enzyme are involved in zymogen inactivation; such mechanism, not previously reported, might be common for apicomplexan proteases similar to Pf PMX. The maturation of Pf PMX zymogen occurs through cleavage of its prosegment at multiple sites. Our data provide thorough insights into the mode of binding of a substrate and a potent inhibitor 49c to Pf PMX. We present molecular details of inactivation, maturation, and inhibition of Pf PMX that should aid in the development of potent inhibitors against pepsin-like aspartic proteases from apicomplexan parasites.